582 Companies
Clinical-stage biopharmaceutical company vTv Therapeutics Inc. is at the forefront of developing orally administered treatments for diabetes. The company's standout drug candidate, liver-selective ...
vTv Therapeutics Inc. Annual Report 2023IntelGenx is a Montreal-based oral drug delivery company that specializes in developing and manufacturing pharmaceutical oral films utilizing its proprietary VersaFilm® technology. The company offe...
Intelgenx Technologies Corp Annual Report 2023CollPlant Biotechnologies Ltd., a pioneering company in the field of regenerative and aesthetic medicine, is focused on adopting three-dimensional (3D) bioprinting for tissue and organ generation, ...
CollPlant Biotechnologies Ltd. Annual Report 2023Entasis is a biopharmaceutical company dedicated to developing innovative antibacterial products that treat severe infections caused by multiplex-resistant Gram-negative bacteria. Their platform fo...
Entasis Therapeutics Holdings Inc. Annual Report 2021Biofrontera AG is a German biopharmaceutical company that focuses on developing and selling dermatological drugs and medical cosmetics for the care, protection, and treatment of skin. With almost 2...
Biofrontera AG Annual Report 2023Boston-based company Acceleron Pharma specializes in developing protein therapeutics for cancer and rare diseases. The company's products in development include sotatercept and ACE-536, both in Pha...
Acceleron Pharma Inc. Annual Report 2019ProQR Therapeutics N.V. is a biotechnology company that specializes in the development and discovery of novel therapeutic medicines. The company boasts an impressive pipeline of products, including...
ProQR Therapeutics N.V. Annual Report 2023Opiant Pharmaceuticals Inc. is a company on a mission to combat drug addiction and overdose. They have already made a breakthrough with their development of NARCAN® Nasal Spray, which is used to re...
Opiant Pharmaceuticals Annual Report 2020Veracyte, Inc.: The Global Diagnostics Company Leading the Charge in Genomic Sequencing and Cancer Diagnosis Veracyte, Inc. is a transformative diagnostics company with a global presence, offering...
Veracyte Annual Report 2023Rubius Therapeutics, Inc., a prominent biopharmaceutical venture, is devoted to pioneering cutting-edge red cell therapeutics as a means of treating cancer and autoimmune diseases. The firm was onc...
Rubius Therapeutics Annual Report 2020Optec International, Inc. has become a leading player in the market for fuel optimization units in North America and around the world. The California-based company markets its products for a wide r...
OptiBiotix Health Plc Annual Report 2023Cambridge-based biopharmaceutical firm, Agios Pharmaceuticals, Inc. is focused on the innovative discovery and advancement of cellular metabolism medicines. The company's product portfolio includes...
Agios Pharmaceuticals Annual Report 2023Arena Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that specializes in developing oral drugs for a variety of therapeutic areas, including cardiovascular, central nervous syst...
Arena Pharmaceuticals Annual Report 2019Minneapolis-based Celcuity Inc. is a clinical stage biotechnology company that specializes in developing molecularly targeted therapies for cancer patients across the United States. Its CELsignia d...
Celcuity Annual Report 2023Late clinical-stage biopharmaceutical company, Outlook Therapeutics, Inc., is honing in on the development and commercialization of monoclonal antibodies within the ophthalmic industry. With a spec...
Outlook Therapeutics Annual Report 2023